- Report
- May 2024
- 130 Pages
Global
From €6207EUR$6,499USD£5,190GBP
- Report
- September 2021
- 40 Pages
China
From €2483EUR$2,600USD£2,076GBP
- Report
- August 2022
- 119 Pages
Global
From €4298EUR$4,500USD£3,594GBP
- Report
- November 2023
- 353 Pages
Global
From €9073EUR$9,500USD£7,587GBP
- Drug Pipelines
- January 2023
- 30 Pages
Global
From €2626EUR$2,750USD£2,196GBP
Exemestane is a type of drug used to treat lung cancer. It is a type of aromatase inhibitor, which works by blocking the production of estrogen in the body. This helps to reduce the growth of certain types of cancer cells that need estrogen to grow. Exemestane is used to treat postmenopausal women with hormone receptor-positive breast cancer. It is also used to reduce the risk of breast cancer in postmenopausal women who have a high risk of developing the disease.
Exemestane is available in tablet form and is taken orally once a day. It is usually taken for five years or until the cancer has been treated. Common side effects of exemestane include hot flashes, joint pain, fatigue, nausea, and vomiting.
Exemestane is a widely used drug in the treatment of lung cancer. It is an important part of the treatment regimen for many patients, and is often used in combination with other drugs.
Some companies that produce exemestane include Pfizer, Novartis, and AstraZeneca. Show Less Read more